Vallbohmer D, Holscher AH, DeMeester S, DeMeester T, Salo J, Peters J, Lerut T, Swisher SG , Schroder W, Bollschweiler E, Hofstetter W
These distinct conjugation sites reflect the different peptide backbones and the optimization required to maintain triple versus dual receptor activity while accommodating the lipid modification
There are differences in who can use these medications, says Thomas So, PharmD, a clinical pharmacist and the senior manager of the consumer drug information group at First Databank
Lower-dose GLP-1 therapy and what emerging research suggests about inflammation, healthspan, and impulse control
Are you adjusting for side effects